Latest Capital Raises News

Radiopharm Theranostics (ASX: RAD) has requested an immediate voluntary suspension of its shares pending a material capital raising announcement expected before markets open on 27 July 2026.

Breakthrough Minerals has delivered promising assay results from its maiden drilling at Barbara, underpinning resource growth potential, while launching a new drilling campaign at Hazel Creek and securing A$5.15 million to fund an expanded exploration push.

Activeport has raised $3.6 million through an oversubscribed placement led by top-tier investors including Antipodes Partners and Scobie Ward, bolstering its balance sheet to accelerate growth in network automation software.

Prominence Energy outlines a disciplined, capital-efficient plan to advance its South Australian helium and natural hydrogen projects toward drilling in mid-2027, backed by low-cost exploration and strategic funding options.

Tasman Resources is gearing up for dual drilling campaigns at Lake Torrens and Parkinson Dam, supported by a recent $4 million placement and strategic asset sales.

Reach Resources has locked in a fully funded mining and milling agreement with Andel Resources at Murchison South, alongside a 30% increase in its Blue Heaven gold resource to 80,000 ounces at higher grade.

West Cobar Metals made progress on its Salazar scandium and Cobar West copper projects during the June quarter, while deciding not to proceed with its Baxter Fluorspar acquisition and securing $1.05 million in new funding.

Dalaroo Metals has completed the second tranche of its placement, raising $320,000 with direct investment from its board, boosting total funds raised to $1.75 million. The capital will accelerate exploration at its Côte d’Ivoire gold and Greenland rare earth projects.

Complii FinTech Solutions reported modest ARR growth and a key institutional contract in Q4 FY26, while advancing product development and managing cash flow pressures.

Diablo Resources has acquired an 80% stake in the historic Horn Silver Project, complementing its nearby Star Range assets and advancing exploration with a maiden drill program approved.

Tanami Gold has secured $70.5 million through a fully underwritten rights issue to fund its Central Tanami Project development, including a major underground decline and resumed drilling at Jims Gold Mine.

Invex Therapeutics has broadened its preclinical Alzheimer's program with Tessara Therapeutics, while its cash reserves dipped to $4.02 million in Q4 FY26 amid increased research and administrative costs.